Tag: Covid-19
-

Synthetic Antibodies Neutralize Covid-19 Virus Proteins
A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses.
-

NIH Nixes Convalescent Plasma Covid-19 Therapy
An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections.
-

Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-

Covid-19 Vaccines, Therapies – 31 August 2020
The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium.
-

DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-

Vaccine Blocks Covid-19 Infections in Animal Tests
An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways.
-

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-

Institute Assessing Covid-19 Mental Health Programs
A research institute evaluating real-world health outcomes is funding studies of Covid-19 mental health programs for health care workers and low-income communities.
-

Covid-19 Vaccines, Therapies – 17 August 2020
The number of new Covid-19 therapies increased by eight over the past week to 364, while the number of therapies in clinical trials also jumped by eight.
-

Infographic – Split U.S. Decision on Covid-19 Vaccine
While the U.S. pours billions of dollars into vaccines against Covid-19 infections, a large percentage of the American public is still not ready to be vaccinated.